Lowering Drug Costs for American Families Act
Latest action · Dec 17, 2024 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJul 26, 2023
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Lowering Drug Costs for American Families Act
This bill expands the Medicare Drug Price Negotiation Program to include additional drugs and drugs that are covered under private insurance. It also extends certain rebate requirements for covered drugs under Medicare to drugs that are covered under private insurance.
Current law requires the Centers for Medicare & Medicaid Services (CMS) to negotiate maximum prices for brand-name drugs that do not have other generic equivalents and that account for the greatest Medicare spending; the CMS must eventually negotiate the prices of 20 drugs that are covered under Medicare in 2029 and each year thereafter.
The bill requires the CMS to negotiate the prices of 50 drugs beginning in 2029. It also applies the negotiated maximum prices under the program to drugs that are covered under private health insurance, unless the insurer opts out. The CMS, Department of Labor, and Department of Treasury must publish a list of insurers that choose to opt out; insurers must also publicly disclose their decision to opt out.
Current law also requires drug manufacturers to issue rebates to the CMS for brand-name drugs without generic equivalents under Medicare that cost $100 or more per year per individual and for which prices increase faster than inflation. The bill extends these requirements to drugs that are covered under private insurance.
Cosponsors 74
Members who signed on, in the order they did. Signatures ran from Jul 26, 2023 to Sep 27, 2024; 2 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MA | Richard E. Neal | Original | Jul 26, 2023 |
| D-VA | Robert C. "Bobby" Scott | Original | Jul 26, 2023 |
| D-NJ | Andy Kim | Jul 27, 2023 | |
| D-MN | Angie Craig | Jul 27, 2023 | |
| D-MN | Betty McCollum | Jul 27, 2023 | |
| D-MD | David J. Trone | Jul 27, 2023 | |
| D-NV | Dina Titus | Jul 27, 2023 | |
| D-VA | Donald S. Beyer, Jr. | Jul 27, 2023 | |
| D-PA | Dwight Evans | Jul 27, 2023 | |
| D-DC | Eleanor Holmes Norton | Jul 27, 2023 | |
| D-MI | Elissa Slotkin | Jul 27, 2023 | |
| D-MD | Glenn Ivey | Jul 27, 2023 | |
| D-MI | Haley M. Stevens | Jul 27, 2023 | |
| D-GA | Henry C. "Hank" Johnson, Jr. | Jul 27, 2023 | |
| D-MD | Jamie Raskin | Jul 27, 2023 | |
| D-IL | Janice D. Schakowsky | Jul 27, 2023 | |
| D-CA | Jimmy Gomez | Jul 27, 2023 | |
| D-CT | Joe Courtney | Jul 27, 2023 | |
| D-CT | John B. Larson | Jul 27, 2023 | |
| D-CA | Judy Chu | Jul 27, 2023 | |
| D-FL | Kathy Castor | Jul 27, 2023 | |
| D-MD | Kweisi Mfume | Jul 27, 2023 | |
| D-FL | Lois Frankel | Jul 27, 2023 | |
| D-CA | Mike Thompson | Jul 27, 2023 | |
| D-NY | Paul Tonko | Jul 27, 2023 | |
| D-CA | Robert Garcia | Jul 27, 2023 | |
| D-IL | Robin L. Kelly | Jul 27, 2023 | |
| D-FL | Sheila Cherfilus-McCormick | Jul 27, 2023 | |
| D-TN | Steve Cohen | Jul 27, 2023 | |
| D-PA | Susan Wild | Jul 27, 2023 | |
| D-OR | Suzanne Bonamici | Jul 27, 2023 | |
| D-MA | William R. Keating | Jul 27, 2023 | |
| D-NY | Daniel S. Goldman | Aug 1, 2023 | |
| D-NY | Grace Meng | Aug 1, 2023 | |
| D-MP | Gregorio Kilili Camacho Sablan | Aug 1, 2023 | |
| D-VA | Jennifer L. McClellan | Aug 1, 2023 | |
| D-MD | John P. Sarbanes | Aug 1, 2023 | |
| D-CA | Mark Takano | Aug 1, 2023 | |
| D-AZ | Raúl M. Grijalva | Aug 1, 2023 | |
| D-CA | Ted Lieu | Aug 1, 2023 | |
| D-VT | Becca Balint | Aug 8, 2023 | |
| D-MI | Debbie Dingell | Aug 8, 2023 | |
| D-FL | Debbie Wasserman Schultz | Aug 8, 2023 | |
| D-WI | Gwen Moore | Aug 8, 2023 | |
| D-NY | Joseph D. Morelle | Aug 8, 2023 | |
| D-NC | Kathy E. Manning | Aug 8, 2023 | |
| D-CA | Mark DeSaulnier | Aug 8, 2023 | |
| D-RI | Seth Magaziner | Aug 8, 2023 | |
| D-CO | Diana DeGette | Aug 15, 2023 | |
| D-CA | Jimmy Panetta | Aug 15, 2023 | |
| D-CA | Nanette Diaz Barragán | Aug 15, 2023 | |
| D-OR | Andrea Salinas | Aug 22, 2023 | |
| D-GA | Nikema Williams | Aug 22, 2023 | |
| D-CO | Yadira Caraveo | Aug 22, 2023 | |
| D-MI | Daniel T. Kildee | Sep 12, 2023 | |
| D-VA | Gerald E. Connolly | Sep 12, 2023 | |
| D-CA | Katie Porter | Sep 12, 2023 | |
| D-WA | Rick Larsen | Sep 12, 2023 | |
| D-TX | Veronica Escobar | Sep 12, 2023 | |
| D-VA | Abigail Davis Spanberger | Sep 26, 2023 | |
| D-ME | Chellie Pingree | Sep 26, 2023 | |
| D-KS | Sharice Davids | Sep 26, 2023 | |
| D-PA | Matt Cartwright | Sep 28, 2023 | |
| D-NY | Jerrold Nadler | Oct 3, 2023 | |
| D-HI | Jill N. Tokuda | Dec 5, 2023 | |
| D-PA | Summer L. Lee | Feb 26, 2024 | |
| D-CA | Barbara Lee | May 21, 2024 | |
| D-OH | Marcy Kaptur | Jun 25, 2024 | |
| D-CA | Linda T. Sánchez | Jun 28, 2024 | |
| D-NY | Yvette D. Clarke | Jul 22, 2024 | |
| D-TX | Lizzie Fletcher | Jul 24, 2024 | |
| D-CA | Brad Sherman | Aug 2, 2024 | |
| D-CA | Doris O. Matsui | Aug 13, 2024 | |
| D-AZ | Greg Stanton | Sep 27, 2024 |
Committees 3
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Jul 26, 2023 |
| Health Subcommittee | Referred Jul 28, 2023 | |
| House | Ways and Means Committee | Referred Jul 26, 2023 |
| Health Subcommittee | Referred Dec 17, 2024 | |
| House | Education and Workforce Committee | Referred Jul 26, 2023 |
Actions 4
Everything that happened, newest first.
- Dec 17, 2024Referred to the Subcommittee on Health.
- Jul 28, 2023Referred to the Subcommittee on Health.
- Jul 26, 2023Introduced in House
- Jul 26, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Lists H4031–H4033H.R. 4895–4952 | — | Jul 26, 2023 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 129, July 26, 2023, page H4031.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 118-33 | LOWERING COSTS AND INCREASING ACCESS TO HEALTHCARE WITH EMPLOYER-DRIVEN INNOVATION140 pages | Education and Workforce Committee | Jan 11, 2024 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend title XI of the Social Security Act to expand the drug price negotiation program, and for other purposes.
- Short Title(s) as Introduced
- Lowering Drug Costs for American Families Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Jul 26, 2023Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
